STENTARELLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 4.568
EU - Europa 3.099
AS - Asia 713
AF - Africa 16
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 8.413
Nazione #
US - Stati Uniti d'America 4.542
GB - Regno Unito 1.887
SE - Svezia 327
CN - Cina 304
IT - Italia 271
DE - Germania 203
TR - Turchia 151
UA - Ucraina 135
SG - Singapore 93
HK - Hong Kong 89
FI - Finlandia 82
FR - Francia 61
BG - Bulgaria 51
CA - Canada 26
IN - India 21
SI - Slovenia 21
MY - Malesia 16
BE - Belgio 15
ZA - Sudafrica 9
ID - Indonesia 8
NL - Olanda 8
VN - Vietnam 8
JP - Giappone 7
RO - Romania 7
RU - Federazione Russa 7
BR - Brasile 5
IE - Irlanda 5
IR - Iran 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
ES - Italia 4
EU - Europa 4
PK - Pakistan 4
LT - Lituania 3
NG - Nigeria 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
GH - Ghana 2
ZW - Zimbabwe 2
AR - Argentina 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
IQ - Iraq 1
KR - Corea 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8.413
Città #
Southend 1.786
Fairfield 549
Woodbridge 465
Chandler 459
Ashburn 357
Houston 294
Jacksonville 283
Ann Arbor 248
Dearborn 241
Seattle 225
Wilmington 215
Cambridge 199
Nyköping 159
Beijing 117
Modena 111
Izmir 102
Hong Kong 89
Princeton 70
New York 58
Singapore 55
Eugene 51
Sofia 51
San Diego 45
Bremen 32
Helsinki 32
Boardman 26
Shanghai 26
Redwood City 25
Milan 18
London 17
Brussels 12
Falls Church 12
Halifax 12
Norwalk 10
Munich 9
Dong Ket 8
Faenza 8
Jakarta 8
Kunming 8
Nanjing 8
Bengaluru 7
Ferrara 7
Fremont 7
Hefei 7
Chicago 6
Dallas 6
Dongguan 6
Indiana 6
San Mateo 6
Toronto 6
Tulare 6
Augusta 5
Des Moines 5
Dublin 5
Jinan 5
Leawood 5
Phoenix 5
Rome 5
Ardabil 4
Bologna 4
Brno 4
Brooklyn 4
Durban 4
Farmington 4
Los Angeles 4
Nanchang 4
Paris 4
San Francisco 4
Vicenza 4
Washington 4
Amsterdam 3
Atlanta 3
Avellino 3
Chengdu 3
Guangzhou 3
Hounslow 3
Maastricht 3
Madrid 3
Manila 3
Mumbai 3
Newmarket 3
Omaha 3
Perugia 3
San Francisco De Las Llagas 3
Verona 3
Accra 2
Ahmednagar 2
Auburn Hills 2
Baltimore 2
Bangalore 2
Barletta 2
Castelnuovo Rangone 2
Centurion 2
Chavannes-le-Chene 2
Chiswick 2
Cortona 2
Empoli 2
Frankfurt am Main 2
Fuzhou 2
Hangzhou 2
Totale 6.728
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 708
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 670
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 300
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients 214
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 213
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 196
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 194
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 190
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. 187
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 179
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 179
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study 178
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 176
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 171
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 171
Prediction of hard cardiovascular events in HIV patients 170
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 168
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 168
Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment 162
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 160
Should we screen for NAFLD/NASH in HIV patients? 155
Predictors of transitions in frailty severity and mortality among people aging with HIV 154
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 153
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy 152
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 152
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs. 149
Multimorbidity and functional status assessment 143
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 139
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 132
Prevalence and predictors of preclinical coronary heart disease in post-menopause period 132
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 126
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 125
Two methods of measuring frailty among people aging with HIV 124
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 122
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 118
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends 117
MR techiniques in the quantitative assessment of liver steatosis 117
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 112
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT AND NON-PREGNANT WOMEN OF CHILDBEARING AGE 111
How do frailty mediate pathway leading to disability 110
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodistrophy 109
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients - Reply to Remtulla and Decker 106
HR-MAS NMR SPECTROSCOPY FOR CHARACTERIZATION OF STEATOSIC LIVER: FAT QUANTIFICATION FOR A SPECTROSCOPIC DIFFERENTIATION BETWEEN STEATOSIS AND STEATOHEPATITIS 105
Health transitions in HIV-seropositive individulas undergoing NRTI-based and NRTI-sparing treatment strategies. 105
Impact of Antiretroviral Medications on Fasting Lipid Parameters 103
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT WOMEN AND ITS IMPACT ON PREGNANCY OUTCOME 102
Menopause in HIV-infected women: somewhat different? 99
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 98
Renal hyperfiltration and outcome in HIV-infected subjects. 97
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 96
null 49
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 48
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 41
Totale 8.555
Categoria #
all - tutte 28.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.755 0 86 95 109 200 296 283 252 174 77 112 71
2020/20211.546 135 60 138 135 208 127 112 174 89 165 120 83
2021/20221.128 46 159 99 132 19 60 48 72 119 82 160 132
2022/20231.132 118 139 91 117 139 162 9 130 136 20 30 41
2023/2024694 29 47 43 66 155 94 42 85 12 8 43 70
2024/2025101 65 36 0 0 0 0 0 0 0 0 0 0
Totale 8.555